Area of research
Pharmacology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Treatment of Major Depression, Pharmacogenetics and Drug Metabolism, Schizophrenia research and treatment, and Pharmaceutical studies and practices.
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis.
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNP
How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNP.
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective.
Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review.
Citalopram <i>in vitro</i> metabolism in a Beagle dog: A role for CYP2D15 in the production of toxic didesmethylcitalopram?
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.
Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs
The effect of perazine on the CYP2D6 and CYP2C19 phenotypes as measured by the dextromethorphan and mephenytoin tests in psychiatric patients.
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].
About the Misleading Use of Stereodescriptors in Labeling the Stereoisomers of Milnacipran and Levomilnacipran.
Clinical Psychopharmacology in Switzerland.
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].
Erratum zu: Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians
Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression
Therapeutisches Drug-Monitoring in der Psychiatrie